GHK-Cu is studied in copper-peptide coordination and laboratory models involving fibroblast, gene-expression, and extracellular-matrix signaling.
- Copper-peptide coordination
- Gene-expression assays
- Extracellular-matrix signaling
Fibroblast and matrix papers name GHK-Cu
Keep AHK-Cu papers on the AHK-Cu page. The sequences are different even though both are copper peptides labeled 50 mg.
GLOW's GHK-Cu line is 45.17 mg on task 136730, and that line belongs to the blend sample.
Quote both masses
A single number drops either the peptide or the copper. Task 165759 printed both.
This page is laboratory education for adults 21 and older. It is not a dosing guide, a treatment plan, or a ranking of which material to use. Not for human or veterinary use.
GHK-Cu 50 mg research questions
What themes are filed here?
Copper-peptide coordination, gene-expression assays, and extracellular-matrix signaling.
Is GLOW the same listing?
No. GLOW 70 mg is $99.99 and includes BPC-157 and TB-500 as well.
References and further reading
- PubMed literature index — GHK-Cu 50 mg ↗
A continuously updated index of peer-reviewed biomedical literature. Study quality, model, and relevance must be assessed individually.
- FDA — Analytical Procedures and Methods Validation ↗
Regulatory guidance on analytical method development and validation.
- ICH Q2(R2) — Validation of Analytical Procedures ↗
International guidance on specificity, accuracy, precision, range, and robustness.
- Hoofnagle et al. — Recommendations for peptide storage and handling ↗
Peer-reviewed recommendations for peptide handling in quantitative laboratory workflows.
External links are provided for independent literature review. A link does not imply that every indexed paper supports the same conclusion or that findings apply beyond the model and conditions studied.